Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.

Show other versions (1)

Biallelic CEBPA mutations and FMS-like tyrosine kinase receptor 3 (FLT3) length mutations are frequently identified in human acute myeloid leukemia (AML) with normal cytogenetics. However, the molecular and cellular mechanisms of oncogene cooperation remain unclear because of a lack of disease model...

Full description

Bibliographic Details
Main Authors:	Reckzeh, K, Bereshchenko, O, Mead, A, Rehn, M, Kharazi, S, Jacobsen, SE, Nerlov, C, Cammenga, J
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model.
by: Reckzeh, K, et al.
Published: (2012)

ROLE OF BIALLELIC C/EBPALPHA MUTATIONS AND FLT-3 ITD IN INITIATION AND MAINTENANCE OF AML
by: Reckzeh, K, et al.
Published: (2010)

Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML.
by: Bereshchenko, O, et al.
Published: (2009)

Germline counterparts of oncogenic mutations: who gives a JAK?.
by: Mead, A, et al.
Published: (2013)

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.
by: Kharazi, S, et al.
Published: (2011)

Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis
by: Cirilli, M, et al.
Published: (2016)

Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
by: Mu G, et al.
Published: (2020-02-01)

New dual inducible cellular model to investigate temporal control of oncogenic cooperating genes
by: Matthew R. Kent, et al.
Published: (2024-09-01)

ENL mutation and AML: a new model that reveals oncogenic condensate's function in leukemogenesis
by: Zhong Fan, et al.
Published: (2025-01-01)

S128: AML CONDITIONING OF THE BONE MARROW MICROENVIRONMENT THROUGH CCR1 LIGAND UP-REGULATION PROMOTES AML STEM CELL PROPAGATION AND IS MIMICKED BY AGEING
by: Xiying Ren, et al.
Published: (2023-08-01)

In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: early gene expression profiling reveals possible drug target in AML.
by: Anmaar M Abdul-Nabi, et al.
Published: (2010-08-01)

Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
by: Bradley Stockard, et al.
Published: (2021-06-01)

Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks
by: Isabel Bär, et al.
Published: (2020-11-01)

Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation
by: Konstantin Bogdanov, et al.
Published: (2023-08-01)

S119: CEBPA AND TET2 MUTATIONS COOPERATE TO INDUCE AGGRESSIVE AML VIA GATA-2 DOWNREGULATION
by: E. Heyes, et al.
Published: (2022-06-01)

Inflammation-induced cellular changes: Genetic mutations, oncogene impact, and novel glycoprotein biomarkers
by: Xiaotong Wang, et al.
Published: (2024-01-01)

Tafazzin modulates cellular phospholipid composition to regulate AML stemness
by: Ayesh K. Seneviratne, et al.
Published: (2019-09-01)

Delineating the cellular pathways and molecular determinants of normal and leukemic hematopoiesis
by: Jacobsen, SE
Published: (2009)

Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.
by: Hye-Lim Ju, et al.
Published: (2013-01-01)

The molecular and cellular basis for oncogene collaboration in acute myeloid leukaemia
by: Di Genua, C
Published: (2018)

Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML
by: Nicolas Duployez, et al.
Published: (2019-06-01)

Impact of TP53 mutation on genetic and cellular hierarchy profile in complex karyotype AML/MDS with increased blasts
by: Jinha Hwang, et al.
Published: (2024-11-01)

FLT3-ITD INDUCED MYELOPROLIFERATION CAUSES A CELL EXTRINSIC DEPLETION OF HAEMATOPOIETIC STEM CELLS
by: Mead, A, et al.
Published: (2014)

The Oncogenic Signaling Disruptor, NDRG1: Molecular and Cellular Mechanisms of Activity
by: Jason Chekmarev, et al.
Published: (2021-09-01)

Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation
by: Moreau-Gachelin Françoise
Published: (2008-11-01)

Autophagic activity dictates the cellular response to oncogenic RAS.
by: Wang, Y, et al.
Published: (2012)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
by: Georgia Konstantinidou, et al.
Published: (2020-04-01)

ZNF768 links oncogenic RAS to cellular senescence
by: Romain Villot, et al.
Published: (2021-08-01)

Multiplexed single‐cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells
by: Emma Rörby, et al.
Published: (2021-02-01)

Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer
by: Murphy, Charles J., et al.
Published: (2019)

Genetic modelling of PIM proteins in cancer: proviral tagging, cooperation with oncogenes, tumor suppressor genes and carcinogens.
by: Enara eAguirre, et al.
Published: (2014-05-01)

Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation
by: Di Genua, C, et al.
Published: (2017)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
by: Islam, M., et al.
Published: (2017)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
by: Mirazul Islam, et al.
Published: (2017-01-01)

The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model.
by: Esther Tijchon, et al.
Published: (2019-01-01)

Protocol to establish a stable MLL-AF9_AML mouse model
by: Jun Lu, et al.
Published: (2022-09-01)

Molecular characterization of the chromosome 9q deletion in AML.
by: Side, L, et al.
Published: (2000)

IDH1 as a Cooperating Mutation in AML Arising in the Context of Shwachman-Diamond Syndrome
by: Stéphanie Mourad, et al.
Published: (2019-08-01)

Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis
by: ZhongLi Hu, et al.
Published: (2024-12-01)

Explainable AI identifies diagnostic cells of genetic AML subtypes
by: Matthias Hehr, et al.
Published: (2023-03-01)